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Cytoprotective effects of adrenomedullin in glomerular cell injury:
Central role of cAMP signaling pathway. Activation of cAMP signaling
pathway was shown to inhibit some pathohiologic processes in mesangial
cells (MC). We investigated whether adrenomedullin (ADM), a potent
agonist of adenylate cyclase, is synthesized in MC and whether it can, via
cAMP, suppress the generation of reactive oxygen metabolites (RUM)
and proliferation of cells in glomeruli. With the use of an immunohisto-
logic technique ADM was detected in mesangial and microvascular areas
of rat glomeruli. MC grown in primary culture synthesized ADM, and the
synthesis was stimulated by TNFa and 1L-1 but not by PDGF and EGF.
ADM inhibited RUM generation in MC dose-dependently and caused in
situ activation of protein kinase A (PKA). In macrophages (cell line J774)
ROM generation was about four times higher than in MC and was
inhibited by ADM in a similar way as in MC. The rate of MC proliferation,
measured by [3H1-incorporation, and the activity of mitogen-activated
protein kinase (MAPK) stimulated by PDGF and EGF were dose-
dependently inhibited by ADM; the maximum inhibition (at 10 nM ADM)
was about —80%. Mitogenesis of MC and MAPK activity when stimulated
to a similar extent by endothelin (ET-1) was inhibited by ADM to a
significantly (P < 0.01) lesser degree (—30%). Further, ADM inhibited
PDGF-stimulated mitogenesis and activation of MAPK in cultured vas-
cular smooth muscle cells (VSMC). The inhibition of PDGF-activated
MAPK by ADM in VSMC was reversed by the protein kinase A (PKA)
inhibitor, H89. Taken together, results indicate that adrenomedullin
(ADM) generated in mesangial cells (MC) can suppress, via activation of
the cAMP-protein kinase A (PKA) signaling pathway, reactive oxygen
metabolites (ROM) generation in MC and infiltrating macrophages as
well as mitogen-activated protein kinase (MAPK)-mediated mitogenesis
in MC and vascular smooth muscle cells (VSMC). We suggest that
intraglomerular ADM may serve as a cytoprotective autacoid that sup-
presses pathobiologic processes evoked by immuno-inflammatory injury of
glomeruli.
Reactive oxygen mctabolites (RUM) and excessive cell prolif-
eration play important roles in pathogenesis of glomerular injury
[1, 2]. In the course of inflammation, ROM are generated by
infiltrating leukocytes, macrophages [3] and neutrophils [4],
well as by endogenous glomerular cells [5], in particular, by
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mesangial cells (MC) [5—7]. Another major histopathological
feature of many types of immuno-inflammatory glomerular inju-
ries is proliferation of glomerular MC [2, 8]. Recent studies
indicate that activation of the cAMP-dependent protein kinase A
(PKA) signaling pathway can inhibit RUM generation both in
leukocytes [3, 4] and mitogenesis in some cell types [9—12]. In
leukocytes, including macrophages, an increase in intracellular
cAMP can suppress the burst of RUM generation via inhibition of
the NADPH oxidase, a major source of ROM in these cells [13,
14]. We have recently found that activation of the cAMP-PKA
pathway suppresses RUM generation in rat glomeruli [151 as well
as in primary cultured rat glomerular mesangial cells (MC) [16].
Activation of cAMP-PKA pathway in MC also leads to the
decrease of proliferation stimulated by potent mitogens [12],
albeit in a different cell compartment [16].
In view of these observations, it is of major interest to identify
endogenous activators of the cAMP-PKA pathways that may
exhibit cytoprotective effects in immuno-inflammatory injury of
glomerular cells. Of particular interest is a newly discovered
vasoactive peptide, adrenomedullin (ADM), which was found in
numerous mammalian tissues including kidney [17]. In our recent
studies of dog kidney parenchyma, the presence of ADM was
detected almost exclusively in glomeruli and distal segments of the
nephron [18]. ADM, on a molar basis, is a singularly potent
activator of cAMP-PKA pathway in rat MC [19, 20] and other cell
types [21]. We previously observed that ADM inhibition of
primary cultured MC proliferation is inversely correlated with in
situ activation of PKA [191. Based on all these considerations, we
propose a working hypothesis that ADM may play a role as
intrarenal autacoid that has a prominent cytoprotective effects on
pathohiologic processes in MC and in glomeruli via activation of
cAMP-PKA pathway. Herein we report that in rat kidney (a)
ADM is localized in mesangium and microvessels of glomeruli,
and MC can secrete ADM; (h) ADM has blocking effect upon
RUM generation both in MC and macrophages; (c) ADM inhibits
MC proliferation stimulated by some mitogens; and (d) ADM
blocks proliferation of vascular smooth muscle cells (VS MC) in a
manner similar to that in MC. These observations lend support to
the notion that endogenous ADM produced in MC may serve as
an autocrine/paracrine suppressor of pathological responses of
MC, VSMC and macrophagcs and may ameliorate glomerular
injury.
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METHODS
Cell culture
Mesangial cells (MC) were isolated from glomeruli and grown
in a primary culture. Briefly, glomeruli were isolated from 200 g
male Sprague-Dawley rats by differential sieving [12, 16, 191, and
the cell outgrowths were characterized as MC by positive immu-
nohistochemical staining for vimentin, smooth muscle-specific
actin, and negative stains for cytokeratin, factor Vili-related
antigen, and leukocyte common antigen (antibodies from Dako
Corp., Carpintarie, CA, USA). MC from passages 2 to 6, grown in
a RPMI medium with 20% fetal calf serum (FCS), were used for
determination of RUM generation, and MC from 4 to 10 pas-
sages, grown in complete Waymouth's medium with 20% FCS,
were used for determination of mitogenic DNA synthesis by
[3H]-thymidine incorporation [12, 16]. Macrophages of cell line
J774 were obtained from ATCC, and cells were cultured in
Dulbeco-modified Eagles medium (DMEM). Vascular smooth
muscle cells (VSMC) were isolated from rat thoracic aorta
removed from 200 g male Sprague-Dawley rats. VSMC were
outgrowths from aorta explants, as previously described [221.
VSMC were grown in DMEM supplemented with 10% FCS.
VSMC were characterized, as previously [22], by positive immu-
nohistochemical staining for smooth muscle actin and negative
stains for cytokeratin and factor Vu-related antigen (antibodies
from Dako Corp.). VSMC from 4 to 10 passages were used for
experiments. In all experiments cultured cells were used when
they reached confluency and were rendered quiescent for 24 hours
in serum-free media.
Determination of ADM synthesis in MC
Samples for determination of ADM in cell culture incubate
fluid were obtained by aspiration of the medium at different time
periods of incubations. Confluent MC grown in 20% FCS were
washed three times with phosphate-buffered saline (PBS), and the
media was replaced with DMEM without FCS and incubated
without or with cytokines and growth factors at 37°C for 0 to 72
hours, as specified in the Results section. After collection, the
media samples were immediately placed on ice and centrifuged
2500 rpm at 4°C for 15 minutes; the supernatants were frozen and
stored at —70°C until analyzed. The samples of media (1 ml) were
extracted on C-18 columns and eluted with 75% methanol con-
taining 1% TFA [23]. Samples were concentrated by Speed-Vac
and then assayed with specific and sensitive RIA for ADM
(Phoenix Pharmaceuticals, Inc.), using instructions on the RIA
kit.
immunohistochemical staining for ADM was performed by
indirect immunoperoxidase method, as described before [18, 23].
Rat kidneys were fixed and embedded in paraffin and cut in 5 jrm
sections for indirect immunoperoxidase staining, using diamino-
henzidine with nickel and chromogen. After being washed, the
blocks were incubated with rat polyclonal anti-ADM antiserum
(Phoenix Pharmaceuticals, inc.) at a dilution of 1:800 in humidi-
fied chambers for 24 hours at room temperature, and the ADM
immunohistochemical analysis was determined by standard pro-
cedure [18, 231. To determine the specificity of the ADM staining,
an absorption test were performed. The anti-ADM antiserum was
preincubated with 2 JLM rat ADM overnight. After centrifugation
at 3000 X g for three minutes, the supernatant was used instead of
the primary antiserum.
The in situ activation of PKA was determined as the ratio of
PKA activity measured without added cAMP (—cAMP) to the
total PKA activity measured with 1 /LM cAMP (+cAMP) and
expressed as (—cAMP)/(+cAMP) PKA activity ratio as described
previously [12, 15, 16, 19]. Quiescent cells in 90 mm plates were
incubated at 37°C either without (control) or with different
concentrations of ADM. The incubation was terminated by chill-
ing the plates to 0 to 4°C, and MC were quickly scraped in 0.2 ml
of homogenizing buffer. The scraped cells were homogenized and
centrifuged at 27,000 x g for 30 minutes at 0 to 4°C. The PKA
activity was determined in supernatant by incorporation of 32P-y-
ATP into the oligopeptide Kemptide. The incubation was carried
out for 15 to 30 minutes at 30°C with 6 g of protein per assay
tube [12, 16, 19].
[3H1 -thymidine incorporation
Cell proliferation was determined by mitogenic synthesis of
DNA using the [3H]-thymidine pulse-labeling assay [12, 16, 19].
MC or VSMC were plated into 24-well culture dishes at 5 X i04
cells/well and grown for 24 hours to confluence. Cells were
rendered quiescent by incubation in DMEM supplemented with
0.5% FCS for 72 hours [12, 16]. After the addition of test
compounds, cultures were incubated for an additional 16 hours.
Then I tCi/well [3H]-thymidine was added and cells were incu-
bated for four hours prior to determination of [3H]-thymidine
incorporation by filtration technique [12, 16, 19].
Determination of mitogen activated protein kinase
MAPK activity was determined as in our previous studies [12,
19] using the myelin basic protein (MBP) as a substrate. MC or
VSMC grown in 90 mm petri dishes were rendered quiescent as
described above. Cells were incubated with 10 nM ADM for 15
minutes at 37°C and then were treated with mitogens for 10
minutes. The phosphorylated MBP was determined using a paper
filtration method; in preliminary control experiments we deter-
mined that the paper filtration method provides similar results as
that obtained by separation MBP by SDS-PAGE and determined
by autoradiography [12, 16, 19].
Reactive oxygen metabolite generation
RUM generation was measured by a microfluorometric assay
using 2',5'-dichlorodihydrofluorescein diacetate as a probe [16,
24] in cells that were stimulated with serum-opsonized zymosan
(SOZ) [16]. The RUM-induced fluorescence was inhibited by
established RUM scavengers, that is, superoxide dismutase
(SOD), catatase and dimethylthiourea [16, 24]. In the presence of
SOD (40 jtg/ml) the fluorescence was blocked more than 90%
[16]; the SOD-suppressible fluorescence was considered to be due
to ROM generation and is presented in the Results section. This
method detects both extracellular and intracellular RUM [24].
Statistical analysis
Statistical significance of experimental data were evaluated by
ANOVA and/or Student's t-test, as appropriate. Statistical values
of P < 0.05 were considered significant.
RESULTS
Localization of ADM in rat glomeruli was conducted by
immunohistochemical analysis (Fig. 1). We detected the presence
of immunoreactive ADM in rat similarly to what has been found
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Fig. 1. tmmunohistocheniical staining of glomerniar structures in rat kidney cortex with anti-ADM serum. .4. Glomerulus, arrow indicates sites of
prominent positive immunostaining, namely in mesangium and microvessels. B. Control staining with anti-ADM serum preabsorbed with rat ADM. C.
Afferent arteriole at vascular pole of glomerulus.
in previous studies [18]. Within glomeruli the most prominent To determine whether ADM is produced by MC, primary
staining was in the mesangium and endothelium of glomerular cultured rat MC were incubated with or without cytokines in
capillaries and VSMC (Fig. 1). serum-free media, and the amount of ADM released to the
C
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Con TNF IL-i PDGF EGF
Fig. 3. Effect of cytokines and growth factors upon synthesis of ad-
renomedullin (ADM) in mesangial cells (MC). MC were incubated with
various agents for 18 hours, and the ADM concentration in the cultured
media was determined by RIA. Controls (Con); 10 nglml TNF-a (TNF);
10 ng/ml interleukin-1 (IL-i), 10 ng/ml platelet-derived growth factor
(PDGF), 10 ng/ml epithelial growth factor (EGF). *Signiflcantly higher(by r-test) than controls. Each bar denotes mean SCM of three
experiments.
culture media was determined by radioimmunoassay (RIA).
ADM content in medium increased proportionally to elapsed
time, without or with near-maximum doses of TNF-a (Fig. 2A).
TNF-cs stimulated ADM release in a dose-dependent manner; the
maximal increase was +625%; ED5() = 16 ng!ml (Fig. 2B). ADM
was also stimulated by IL-i, similarly as by TNF-a, whereas
neither PDGF nor EGF influenced the rate of ADM production
by MC (Fig. 3).
Next we examined the effect of ADM upon ROM generation in
MC stimulated with serum opsonized zymosan (SOZ) [16]. Incu-
bation of the MC with 10 flM ADM for 15 minutes added prior to
the addition of 1 mg/mI SOZ significantly inhibited ROM gener-
ation (by —25% to 30%; Figs. 4 and 5). The inhibitory effect of
ADM upon ROM generation was dose-dependent (IC50 0.5
nM; Fig. 4). Comparison of the dose-dependent inhibition of
ROM generation by ADM (Fig. 4) with dose-dependent in situ
activation of PKA, assayed under similar conditions and reported
previously [19], showed a strong inverse correlation (with r
—0.998, P < 0.05). Forskolin, which activates maximally cAMP-
Fig. 2. Synthesis of ADM by mesangial cells
(MC): Effect of TNF-a. (A) Time course. Rat
MC were incubated with (•) or without (Lii) 40
ng/ml TNF-a for different periods of time
(abscissa). (B) Dependence of ADM synthesis
upon TNF-a concentration. MC were incubated
with different concentrations of TNF-a
(abscissa) for 18 hours. The ED50 values were
15 nglml TNF. The content of ADM in
cultured media was determined by RIA. Each
point denotes mean SEM of N = 3
experiments.
Fig. 4. Effect of adrenomedullin (ADM) upon serum opsonized zymosan
(SOZ)-stimulated reactive oxygen metabolites (ROM) generation in
mesangial cells (MC). The figure shows the dose-dependent inhibitory
effect of ADM upon ROM generation. The cells were preincubated with
different concentrations of ADM prior to addition of 2 mglml SOZ.
Abscissa: ADM concentration on log scale; ordinate = % inhibition of
ROM generation. Each point denotes mean SCM, N = 3.
PKA in MC [10, 16], decreased ROM generation in MC to a
similar degree as ADM. (data not shown).
Addition of 10 nM ADM to macrophages (cell line J774) grown
in vitro, resulted in increase of the in situ PKA activity in
macrophages (—cAMP/+cAMP PKA activity ratio; Controls,
0.1 0.02; mean SCM, with 10 nM ADM, 0.3 0.06; mean
SCM), thus indicating that ADM receptors, coupled positively to
adenylate cyclase, are probably present in these cells and stimu-
late the cAMP-PKA pathway. ROM generation in J774 cells,
stimulated by incubation with SOZ in a similar way as MC, was
fourfold higher than in MC (Fig. 5). Preincubation of the J774
macrophages for 15 minutes with ADM prior to the addition of
SOZ lead to a significant (% to 19 2%; N = 5) decrease in the
ROM generation (Fig. 5), and a similar inhibition was observed in
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With respect to the antiproliferative actions of ADM, we
compared the effect of ADM upon proliferation of MC induced
by several mitogens that act via three distinct signaling pathways:
PDGF, EGF, and endothelin 1 (ET-1). These mitogens were used
in concentrations that stimulated MC proliferation to a similar
degree, that is, about threefold (Fig. 6A). ADM suppressed MC
proliferation elicited by all three mitogens but to a different
degree (Fig. 6B). Proliferation of MC stimulated by PDGF or by
EGF was suppressed dose-dependently by ADM to a similar
degree, and at 10 nt ADM the inhibition was near-maximal
(—80%). In contrast, the ET-1-stimulated MC proliferation was
little or not inhibited at 1 nM ADM, and at 10 nM ADM the
inhibition was significantly (P < 0.05) less extensive (—30%) than
when proliferation of MC was stimulated by the two other
mitogens (Fig. 6B).
MC were incubated with PDGF, EGF and ET-1 at concentra-
tions that stimulated MAPK activity to a similar degree (Fig. 7A).
ADM inhibited dose-dependently and to the same extent the
MAPK stimulated by PDGF and EGF. In contrast, MAPK
stimulated by ET-1 was inhibited by ADM only at the highest
concentration used (10 nM) and to much lesser degree than
MAPK activated by EGF and PDGF (Fig. 7B).
Finally, we explored the effects of ADM upon mitogenesis (Fig.
8A) and activation of MAPK (Fig. 8B), under ambient condition
when stimulated by PDGF, in cultured VSMC (Fig. 8). In contrast
to PDGF, ET-1 had only marginal mitogenic effect upon prolif-
eration of VSMC (data not shown). Incubation of VSMC with
ADM resulted in in situ activation of PKA (data not shown).
Mitogenesis in VSMC was dose-dependently (IC60 0,3 nM
ADM) inhibited by ADM both in the ambient state and when
stimulated by PDOF (Fig. SA). Likewise, the stimulation of
PDGF by MAPK was almost completely blocked by an inclusion
of 10 nrvi ADM, and the PKA inhibitor H89 reversed the
inhibitory effect of ADM (Fig. SB).
DISCUSSION
Recent studies indicate that both reactive oxygen metabolism
(ROM) generation and excessive proliferation of renal cells can
be inhibited by activation of the cAMP-protein kinase A (PKA)
signaling pathway [12, 16, 25]. This suggests that local agonists of
the cAMP pathway may play a significant role as cytoprotectors
against an inflammatory insult. Results of studies presented
herein provide several lines of evidence in support of our hypoth-
esis that adrenomedullin (ADM) synthesized locally in glomerular
cells exerts cytoprotective effects.
Immunoreactive ADM is present in mesangial and microvascu-
lar cells of glomeruli (Fig. 1); this observation is consistent with
previous report that ADM is abundant in glomeruli of dog kidney
[18] and that ADM can be secreted by endothelial cells and
vascular smooth muscle cells (VSMC) [26, 27]. We found that
mesangial cells (MC) grown in in vitro culture can secrete ADM
into the media (Fig. 2). Therefore, within glomeruli ADM may be
produced not only in VSMC [26] and endothelial cells [27] but
also in MC, a cell type that represents about 25% of all cells
populating the glomerulus [281. It seems probable that the rate of
synthesis and release of ADM in glomerular cells may be sufficient
to reach ADM levels that stimulate cAMP-PKA pathways [19, 20].
ADM may thus function as an autocrine-paracrine agonist of the
cAMP-PKA pathway in vivo. The rate of ADM synthesis in vitro
may not quantitatively reflect in vivo conditions. Unlike its action
in vitro, ADM synthesis in vivo is under the stimulatoty effect of
cytokines (Fig. 3) [26], hormones such as glucocorticoids and
thyroxine [29], and can be inhibited by cAMP-increasing agents
[30]. Of interest is the fact that synthesis of ADM in MC can be
stimulated by pro-inflammatory cytokines, similarly as in VAMC
[26], but not by growth factors (Fig. 3). These observations raise
the possibility that pro-inflammatory cytokine mediators of cell
injury such as TNF-a and IL-i (Fig. 3) trigger the production of
ADM in MC, a response that can serve as a negative-feedback
protective mechanism to diminish the pathobiologic responses of
MC to immune-inflammatory injury.
The exact role of ROM generated by MC in cellular mechanism
of glomerular injury is not yet fully clarified. According to recent
studies ROM generated in MC may not necessarily result in toxic
damage [31] but may, as observed for example in smooth muscle
cells [24, 32], activate MAPK pathways, in particular the "classic"
ERK pathway [321. On the other hand, the quantum of ROM
generated by macrophages that infiltrate glomeruli can he sub-
stantially higher than in MC (Fig. 5) and could conceivably exert
a toxic effect leading to cell death by apoptosis or necrosis; ADM
inhibits ROM generation in both MC and macrophages (Fig. 5).
ADM inhibits ROM production to a similar (%) degree as
forskolin, a potent direct stimulator of adenylate cyclase that
maximally activates the cAMP-PKA pathway in MC [12, 16]. This
A
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B
Fig. 5. Effect of adrenomedullin (ADM) upon
reactive oxygen metabolites (ROM) generation
by mesangial cells (MC) (A) and by
macrophages (B) stimujated with serum
opsonized zymosan (SOZ). The experiments
were conducted as described in legend to
Figure 4. Each bars denote mean SEM of
N = 3 experiments. Note that ordinates for MC
and macrophages have different scales.Control ADM Control ADM
ADM, flM
Fig. 6. Effect of adrenomedullin (ADM) upon [3H].thymidine incorpo.
ration in mesangial cells (MC) stimulated by mitogens. (A) Rat MC were
incubated with different mitogens, all in concentration of 10 ng/ml, and
[3H}-thymidine incorporation was determined after 18 hours as described
in the Methods section. The bars denote (%) difference (mean SEM,N = 4) of [3H]-thymidine incorporation from control values, taken as
100%. *Denotes significant (1-test, P < 0.01; N = 4) difference from
controls. Values for PDGF, EGF anbd FT-I were not different from each
other. (B) Dose-dependent effect of ADM upon [3H1-thymidine incorpo-
ration in the presence of 10 ng/ml PDGF (0); 10 nglml EGF (LII); and 10
ng/ml ET-1 (S). Abscissa: Concentration of ADM on log scale. *Denotes
values significantly (by (-test, N = 4; P < 0.05) different from controls.
#Denotes PDGF and EGF values significantly (1-test, P < 0.05) different
from controls and also from corresponding value for ET-.I. No significant
difference was detected between PDGF and EGF (N = 4).
ADM, flM
Fig. 7. Effect of (adrenomedullin (ADM) upon mitogen activated protein
kinase (MAPK) activity in mesangial cells (MC) stimulated by mitogens.
(A) MC were incubated with the different mitogens (10 ng/ml) for 10
minutes, and the MAPK activity was determined as described in the
Methods section. Each bar denotes mean SCM, of N = 4. *Denotes
values significantly ((-test, P < 0.05) different from controls. Values for
PDGF, EGF and ET-1 were not significantly different from each other.
(B) Dose-dependent effect of ADM upon mitogen-stimulated activity of
MAPK in MC. The data are expressed as relative change (%) to control
without ADM taken as 100%. MAPK activity in the presence of 10 nglnil
PDGF (0); 10 ng/rnl EGF (L1);and 10 ng/ml ET-1 (•).Abscissa: Concen-
tration of ADM on log scale. Each point denotes mean SEM, N = 4.
*Values for ET- I significantly ((-test; P  0.05) different from controls and
from PDGF and EGF. All values for PDGF and EGF were significantly
((-test) diflrent from controls and from Er-i values at all ADM concen-
trations.
finding, as well as a close inverse correlation between the increase
in in situ activity of PKA [19] and a decrease of ROM generation
in MC in response to various doses of ADM (Fig. 4), further
support the notion that ADM suppresses ROM generation in MC
via the cAMP-PKA pathway. Also, in macrophages ADM both
inhibits ROM generation (Fig. 5) and activates PKA (Results).
Even in the presence of a potent stimulus for cAMP generation,
such as forskolin, ROM generation was only partially suppressed.
This feature suggests that NADPH oxidase is only in part sensitive
to inhibition by cAMP-PKA signaling pathways. We suggest that
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ADM can activate the cAMP-PKA pathway and thereby inhibit
the assembly and activation of NADPH oxidase that is present
both in MC [5—7, 161 and in macrophages [3, 33]. Since relative(%) inhibition of ROM generation in macrophages and MC by
ADM is about the same (Fig. 5), the net decrease of ROM
generation in glomerulus infiltrated by macrophages would he
greater due to the ADM action on macrophages.
Concerning mitogenesis, ADM inhibits MC proliferation (Fig.
6B) and activity of MAPK (Fig. 7B) prestimulated by dimerizing
growth factors PDGF and EGF or by vasoactive peptide ET-1 that
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Fig. 8. Effect of adrenomedullin (ADM) upon [3H]-thymidine incorpo-
ration and mitogen activated protein kinase (MAPK) activity in vascular
smooth muscle cells (VSMC). (A) A dose-dependent effect of ADM upon
VSMC proliferation is shown. Each point denotes net [3H]-thymidine
incorporation (dpms/4 hr) in "ambient condition" (no additions) (•); with
10 ng/ml PDGF (•). The effect of different concentrations of ADM
(abscissa, log scale) was determined by incubation of the cells with ADM
for 15 minutes prior to the addition of the mitogen. Each point denotes
mean SE of N = 3 experiments. (B) Effect of ADM upon PDGF-
stimulated activity of MAPK. MAPK activity was determined as described
in the Methods section. The data are expressed as relative changes (%)
from controls taken as 100%. (A) Control (no addition); (B) with 10 ng/ml
PDGF (11) mm); (C) incubation with 10 ni ADM for 15 minutes prior to
the addition of 10 ng/ml PDGF; (D) incubation with 10 M H-89 prior to
the addition of ADM and PDGF as in C. 11-89 had no effect upon basal
or PDGF-stimulated activity of MAPK. *Values significantly different
(t-test, P < 0.05) from A and C; value C was nut significantly different
from control (A).
acts via trimeric 0-protein [34]. However, whereas ADM sup-
presses profoundly and to a similar degree both MC proliferation
and activation of MAPK elicited by EOF or by PDGF (Figs. 6A
and 7A), the stimulation of MC proliferation and of MAPK
activation by ET-i were both inhibited to a far lesser degree by
ADM (Figs. 6 and 7). A key step in the MAPK signaling pathway
is the activation of raf-1 kinase [10, 11, 35], and phosphorylation
of raf-1 by PKA decreases its activity [36, 37]. Since raf-] protein
kinase is an initial step in a highly amplified MAPK phosphory-
lation cascade [38], even a modest decrease in activity of raf-1 can
have a profound inhibitory effect upon the activation of MAPK
and stimulation of mitogenesis [38]. In contrast to raf-1, the
isozyme raf-A lacks a consensus sequence for PKA phosphoryla-
tion at 43Ser in the N-terminal region of the molecule [36, 39] and
is slightly inhibited by the cAMP-PKA pathway [40]. We found
that both raf-1 and raf-A are present in MC (analysis of extracts
from MC analyzed by immunoprecipitation with specific antibod-
ies and by Western blot showed the presence of both raf-J and
raf.A; EN. Chini and T.P. Dousa, unpublished results), a finding
consistent with a report of high expression of raf-A mRNA in
renal tissue [41].
It is likely that ADM suppresses MC proliferation and MAPK
activation [12, 19] due to an inhibition of the raf-1 via phosphor-
ylation by activated PKA [36, 37]. While growth factors PDGF
and EGF activate raf-] predominantly via a GTP-Ioaded Ras
mechanism [35, 42], ET-1 activates raf kinases via PKC phosphor-
ylation [34, 42] at sites that are present both in raf-1 and raf-A [36,
37, 391. Thus, ET-1 may activate both raf-1 and raf-A in MC, but
only raf-1 can be inhibited via the cAMP-PKA pathway, a
mechanism similar to that observed in cardiomyocytes [40]. This
putative scenario suggests a tentative explanation of why ADM
inhibited MAPK and mitogenesis only partially when activated by
ET-1 (Figs. 6 and 7), and should be elucidated in future studies.
Interestingly, ADM was shown to suppress PDGF-stimulated
synthesis of ET-1 in MC [43]. Thus, it should be considered that
an elevated ADM content in glomeruli can decrease synthesis of
ET-1 in MC [43], which thereby diminishes the mitogenic stimu-
lation of MC elicited by ET-1 via such an indirect mechanism.
Microvessels that are part of a vascular pole of the glomerulus
are an important component in the regulation of glomerular
functions. Injury of the renal microvessels accompanied by pro-
liferation of VSMC is associated with a number of glomerulopa-
thies, namely those accompanied by vasculitis or hypertension [2].
Our findings that ADM inhibits PDGF-stimulated mitogenesis
(Fig. 8A) and MAPK activation (Fig. 8B) in VSMC, and that the
inhibition was reversed by a specific PKA inhibitor similarly as in
MC [12] suggest that ADM exerts antiproliferative effects, via the
cAMP pathway, not only upon MC but also upon VSMC within
glomeruli and/or in microvessels adjacent to glomeruli.
Besides the cytoprotective effects reported herein, ADM may
also conceivably act to dampen other components of pro-inflam-
matory processes. ADM may act as anti-migration factor [44] and
can inhibit secretion of a cytokine-induced neutrophil chemoat-
tractant, a member of the interleukin-8 family [45]. Biosynthesis
of TNFa in macrophages and its release is blocked by cAMP [46,
47]; thus, by activating the cAMP-PKA pathway ADM may
suppress generation of this pro-inflammatory cytokine. In short,
ADM has the potential to exert cAMP-mediated cytoprotective
effects by suppressing a number of key pathobiologic components
of immune-inflammatory injury in glomeruli.
In conclusion, our findings indicate that adrenomedullin
(ADM) is located in the mesangial-vascular areas of glomeruli
and is hiosynthesized by mesangial cells. We suggest that intra-
glomerular ADM can, via activation of cAMP-protein kinase A
pathway, suppress several pathobiologic processes and thereby
can serve in multiple ways as a cytoprotective factor, and may play
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an important role as defense mechanisms in inflammatory gb-
merular injuries.
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APPENDIX
Abbreviations used in this paper are: adrenomedullin (ADM), reactive
oxygen metabolites (ROM), mesangial cells (MC), vascular smooth mus-
cle cells (VSMC), protein kinase A (PKA), mitogen activated protein
kinase (MAPK), endothelin I (ET-I). cyclic-3',S'-phosphodicstcrasc
(PDE).
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